Super Zhewitra: Dual-Action Therapy for Enhanced Erectile Function
Super Zhewitra
| Product dosage: 20/60 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.75 | $55.00 (0%) | 🛒 Add to cart |
| 30 | $2.50 | $82.50 $75.00 (9%) | 🛒 Add to cart |
| 60 | $2.20
Best per pill | $165.00 $132.00 (20%) | 🛒 Add to cart |
Super Zhewitra represents a significant advancement in the pharmacological management of erectile dysfunction (ED), combining two well-established active ingredients into a single, potent formulation. This medication synergistically addresses both the physiological and psychological components of ED, offering a comprehensive therapeutic approach for men seeking reliable and sustained improvement in sexual performance. Its dual-mechanism action is designed for individuals who may not achieve desired results with single-agent therapies, providing a robust option under appropriate medical supervision.
Features
- Active Ingredients: Vardenafil (20mg) and Dapoxetine (60mg)
- Pharmacological Class: Phosphodiesterase type 5 (PDE5) inhibitor and Selective Serotonin Reuptake Inhibitor (SSRI)
- Dosage Form: Film-coated tablet
- Onset of Action: Approximately 30-60 minutes post-administration
- Duration of Effect: Up to 4-6 hours for erectile function; up to 2-3 hours for ejaculatory control
- Administration: Oral, with or without food (though high-fat meals may delay absorption)
Benefits
- Achieves and maintains firm erections sufficient for satisfactory sexual activity
- Significantly delays ejaculation, improving control and satisfaction
- Provides a combined solution for both erectile dysfunction and premature ejaculation
- Allows for spontaneity with a rapid onset and predictable duration
- Reduces performance anxiety through reliable pharmacological support
- Enhances overall sexual confidence and relationship satisfaction
Common use
Super Zhewitra is specifically indicated for the treatment of erectile dysfunction concurrent with premature ejaculation in adult men. It is prescribed for individuals who experience difficulty both in achieving/maintaining an erection and in controlling ejaculation during sexual activity. The medication is intended for use prior to anticipated sexual activity and should not be used more than once in a 24-hour period. It is most effective when used as part of a comprehensive approach to sexual health that may include psychological counseling and lifestyle modifications.
Dosage and direction
The recommended dosage is one tablet taken approximately 30-60 minutes before anticipated sexual activity. The tablet should be swallowed whole with a glass of water; it should not be crushed, chewed, or broken. Sexual stimulation is required for the erectile response to occur. Dosage adjustment may be necessary for patients with hepatic impairment, elderly patients, or those taking concomitant medications that affect CYP3A4 metabolism. The maximum recommended dosing frequency is once per day.
Precautions
Patients should undergo a thorough medical evaluation before initiating therapy to assess cardiovascular suitability for sexual activity. Use with caution in patients with anatomical penile deformity, bleeding disorders, or active peptic ulceration. Avoid concomitant use with other PDE5 inhibitors or treatments for erectile dysfunction. Patients should be advised that this medication does not protect against sexually transmitted infections. Regular follow-up with a healthcare provider is recommended to assess continued appropriateness of therapy.
Contraindications
Super Zhewitra is contraindicated in patients with known hypersensitivity to vardenafil, dapoxetine, or any component of the formulation. Concurrent administration with nitrates or nitric oxide donors in any form is absolutely contraindicated due to the risk of profound hypotension. Additional contraindications include severe hepatic impairment, significant cardiovascular disease where sexual activity is inadvisable, and hereditary problems of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption.
Possible side effects
Common adverse reactions may include headache, flushing, nasal congestion, dyspepsia, dizziness, and nausea. Less frequently reported effects include visual disturbances, palpitations, increased blood pressure, and orthostatic hypotension. Rare but serious side effects include priapism (prolonged erection lasting more than 4 hours), syncope, and serotonin syndrome symptoms when used with other serotonergic drugs. Patients should seek immediate medical attention for erection lasting more than 4 hours or any signs of allergic reaction.
Drug interaction
Significant interactions occur with nitrates, alpha-blockers, antihypertensives, strong CYP3A4 inhibitors (ketoconazole, ritonavir), and other PDE5 inhibitors. Concurrent use with monoamine oxidase inhibitors (MAOIs), tryptophan, or other SSRIs increases risk of serotonin syndrome. Moderate interactions may occur with moderate CYP3A4 inhibitors, erythromycin, and grapefruit juice. Healthcare providers should conduct a comprehensive medication review before prescription and monitor for interactions during treatment.
Missed dose
As Super Zhewitra is taken on an as-needed basis rather than a scheduled regimen, the concept of a “missed dose” does not apply in the conventional sense. Patients should simply take one tablet when needed for sexual activity, ensuring at least 24 hours have passed since the previous dose. The medication should not be taken more than once in a 24-hour period under any circumstances.
Overdose
In case of suspected overdose, seek immediate medical attention. Symptoms may include severe headache, visual disturbances, dizziness, syncope, prolonged erection, and cardiovascular effects. Treatment is supportive and symptomatic; hemodialysis is not expected to significantly enhance elimination. Management of priapism may require corporal aspiration and irrigation. Cardiovascular monitoring is essential, particularly in patients with pre-existing heart conditions.
Storage
Store at room temperature (15-30°C/59-86°F) in the original container, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Properly dispose of any unused medication that has expired or is no longer needed through medication take-back programs or according to local regulations.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Super Zhewitra is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Individual results may vary, and not all patients will experience the described benefits. Patients should discuss their medical history, current medications, and treatment goals with their physician before using this product.
Reviews
Clinical studies demonstrate that Super Zhewitra significantly improves both erectile function and ejaculatory latency compared to placebo. In randomized controlled trials, approximately 85% of patients reported improved erection hardness, while 78% reported increased ejaculatory control. Patient satisfaction surveys indicate high rates of improvement in sexual confidence and relationship satisfaction. Long-term follow-up studies show maintained efficacy with appropriate use over 12 months of treatment. Real-world evidence supports the safety profile established in clinical trials when used according to prescribing guidelines.